Prostate cancer treatment.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011944:Receptors, Androgen / Q000187:drug effects*; D011987:Receptors, Steroid / Q000187:drug effects*
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D011944:Receptors, Androgen; D011987:Receptors, Steroid